All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • TavoceptLP-300, BNP7787Phase 21 trial

    Lantern Pharma Inc. · Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

  • TB511Phase 21 trial

    Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer

  • TCMCB07Phase 21 trial

    Endevica Bio · Cancer Weight Loss

  • TD001Phase 21 trial

    T.O.A.D. Oncology SA · Metastatic Castration-Resistant Prostatic Cancer

  • TenalisibRP6530Phase 21 trial

    Rhizen Pharmaceuticals SA · Triple Negative Breast Cancer (TNBC)

  • TER-2013Phase 21 trial

    Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer

  • TG4001Phase 21 trial

    Transgene · HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma

  • TG4050Phase 21 trial

    Transgene · Squamous Cell Carcinoma of Head and Neck

  • TGX-007Phase 21 trial

    Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma

  • TH9619Phase 21 trial

    One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck

  • TILT-123Ad5, 3-E2F-d24-hTNFa-IRES-hIL2Phase 21 trial

    TILT Biotherapeutics Ltd. · Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma

  • TJ004309Phase 21 trial

    TJ Biopharma Co., Ltd. · Advanced Solid Tumor

  • TJ102Phase 21 trial

    Phrontline Biopharma · Ovarian Cancer

  • TK216Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Sarcoma, Ewing

  • TL117Phase 21 trial

    Suzhou Junde Biotechnology Co., Ltd · Head and Neck Squamous Cell Carcinoma

  • TL118Phase 21 trial

    Teligene US · Solid Tumor

  • TL938Phase 21 trial

    Teligene US · Colorectal Cancer Metastatic, Advanced Colorectal Cancer

  • TNG260Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer

  • TNG456Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant

  • TQB3126Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Breast Cancer

  • TQB3201Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Metastatic Castration-resistant Prostate Cancer

  • TRI-611Phase 21 trial

    TRIANA Biomedicines, Inc. · ALK-positive NSCLC, ALK-Positive Lung Cancer, ALK-positive Non-small Cell Lung Cancer

  • TST003Phase 21 trial

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Locally Advanced Solid Tumor, Metastatic Tumor, Colorectal Adenocarcinoma

  • TT-10Phase 21 trial

    Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer

  • TUB-030Phase 21 trial

    Gilead Sciences · Advanced Solid Tumors, HNSCC, SCLC

  • TXN10128Phase 21 trial

    Txinno Bioscience Inc. · NSCLC (Non-small Cell Lung Cancer)

  • TY-302Phase 21 trial

    TYK Medicines, Inc · Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • TYK-01054Phase 21 trial

    TYK Medicines, Inc · Solid Tumor Malignancies, Malignant Mesothelioma (MM)

  • UI-102Phase 21 trial

    United Immunity, co., Ltd. · Advanced Cancer

  • VAL-083Phase 21 trial

    Kintara Therapeutics, Inc. · Glioma, Glioblastoma, Glioblastoma Multiforme

  • ValaciclovirPhase 21 trial

    Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

  • VBC101Phase 21 trial

    VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies

  • VBC103Phase 21 trial

    VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies

  • VBC106Phase 21 trial

    VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies

  • VBC108Phase 21 trial

    VelaVigo Bio Inc · Advanced Solid Tumors

  • VBC117Phase 21 trial

    VelaVigo Bio Inc · Advanced Solid Tumors

  • VERT-002PFL-002Phase 21 trial

    Pierre Fabre Medicament · Solid Tumor, MET Alteration

  • VIB305Phase 21 trial

    Vibrant Sciences Limited · Advanced Solid Tumors

  • VIR-5818Phase 21 trial

    Vir Biotechnology, Inc. · Locally Advanced or Metastatic HER2-Expressing Cancers

  • VLS-1488Phase 21 trial

    Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer

  • VMD-102Single agentPhase 21 trial

    VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)

  • VMD-928Phase 21 trial

    VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer

  • vopimetostatPhase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • VP-16Phase 21 trial

    Sichuan Honghe Biotechnology Co., Ltd. · Recurrent Glioblastoma

  • VRN110755Phase 21 trial

    Voronoi, Inc · EGFR-Mutant Non-Small Cell Lung Cancer

  • VS-101Phase 21 trial

    VSPharmTech Co.,Ltd. · Head and Neck Cancer Squamous Cell Carcinoma

  • VTRU200Phase 21 trial

    Vitruviae · Acute Myeloid Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), High Risk Myelodysplastic Syndrome

  • VVD-133214Phase 21 trial

    Vividion Therapeutics, Inc. · Colorectal Adenocarcinoma

  • WEF-001Phase 21 trial

    Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

NewerPage 25 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.